Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Change in Receivables: 2010-2025

Historic Change in Receivables for Neogen (NEOG) over the last 15 years, with Aug 2025 value amounting to -$17.6 million.

  • Neogen's Change in Receivables fell 267.12% to -$17.6 million in Q3 2025 from the same period last year, while for Aug 2025 it was -$24.4 million, marking a year-over-year decrease of 177.50%. This contributed to the annual value of -$11.6 million for FY2025, which is 157.90% down from last year.
  • Neogen's Change in Receivables amounted to -$17.6 million in Q3 2025, which was down 602.87% from -$2.5 million recorded in Q2 2025.
  • Neogen's Change in Receivables' 5-year high stood at $49.3 million during Q4 2022, with a 5-year trough of -$17.6 million in Q3 2025.
  • Moreover, its 3-year median value for Change in Receivables was -$536,000 (2024), whereas its average is $25,727.
  • Its Change in Receivables has fluctuated over the past 5 years, first skyrocketed by 790.01% in 2022, then crashed by 267.12% in 2025.
  • Neogen's Change in Receivables (Quarterly) stood at $5.5 million in 2021, then skyrocketed by 790.01% to $49.3 million in 2022, then tumbled by 74.41% to $12.6 million in 2023, then crashed by 104.25% to -$536,000 in 2024, then plummeted by 267.12% to -$17.6 million in 2025.
  • Its Change in Receivables was -$17.6 million in Q3 2025, compared to -$2.5 million in Q2 2025 and -$3.8 million in Q1 2025.